Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients
暂无分享,去创建一个
Saeid Nahavandi | Afshin Shoeibi | Roohallah Alizadehsani | Abbas Khosravi | Mohaddeseh Behjati | Maryam Panahiazar | Assef Zare | Sadiq Hussain | Zahra Alizadeh Sani | Mohamad Roshanzamir | U Rajendra Acharya | Fahime Khozeimeh | Fereshteh Hasanzadeh | Sheikh Mohammed Shariful Islam | Zahra Roshanzamir | Niloofar Abedini | Pardis Moradnejad
[1] Qiurong Ruan,et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China , 2020, Intensive Care Medicine.
[2] L. French,et al. Onset of occupational hand eczema among healthcare workers during the SARS‐CoV‐2 pandemic: Comparing a single surgical site with a COVID‐19 intensive care unit , 2020, Contact dermatitis.
[3] Joseph M. Campos,et al. 544. Severe COVID-19 in Children and Young Adults in the Washington DC Metropolitan Region , 2020 .
[4] A. Shamshiri,et al. Coincidence of COVID-19 epidemic and olfactory dysfunction outbreak in Iran , 2020, medRxiv.
[5] L. Mombaerts,et al. A machine learning-based model for survival prediction in patients with severe COVID-19 infection , 2020, medRxiv.
[6] Carol H. Yan,et al. Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms , 2020, International forum of allergy & rhinology.
[7] S. Nahavandi,et al. Risk factors prediction, clinical outcomes, and mortality in COVID‐19 patients , 2020, medRxiv.
[8] J. Siegler,et al. Falling stroke rates during COVID-19 pandemic at a Comprehensive Stroke Center: Cover title: Falling stroke rates during COVID-19 , 2020, Journal of Stroke and Cerebrovascular Diseases.
[9] N. Tatonetti,et al. Testing the association between blood type and COVID-19 infection, intubation, and death , 2020, medRxiv.
[10] N. Zhang,et al. Epidemiological characteristics and clinical features of 32 critical and 67 noncritical cases of COVID-19 in Chengdu , 2020, Journal of Clinical Virology.
[11] Xiaogang Shu,et al. Effect of Gastrointestinal Symptoms in Patients With COVID-19 , 2020, Gastroenterology.
[12] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[13] J. Frans,et al. Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study , 2020, Journal of the American Medical Directors Association.
[14] G. Sayer,et al. Characteristics and Outcomes of Recipients of Heart Transplant With Coronavirus Disease 2019. , 2020, JAMA cardiology.
[15] Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China , 2020, Infection.
[16] James M. Blum,et al. Characteristics and Clinical Outcomes of Adult Patients Hospitalized with COVID-19 — Georgia, March 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[17] Véronique Sébille,et al. Inhibition of the interaction between the SARS-CoV Spike protein and its cellular receptor by anti-histo-blood group antibodies , 2008, Glycobiology.
[18] Rachel M. Kenney,et al. Early Short-Course Corticosteroids in Hospitalized Patients With COVID-19 , 2020, medRxiv.
[19] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[20] A. Ahmadi,et al. Comparison of Clinical, Laboratory and Radiological Findings in Iranian Smokers and non- Smokers Patients with COVID-19: A Case Control Study , 2020 .
[21] Bolin Wang,et al. Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis , 2020, Aging.
[22] Saniya Gupta,et al. Connecting BCG Vaccination and COVID-19: Additional Data , 2020, medRxiv.
[23] F. Faraji,et al. Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19 , 2020, International forum of allergy & rhinology.
[24] Yu Tao,et al. Risk Factors for Mortality in 244 Older Adults With COVID‐19 in Wuhan, China: A Retrospective Study , 2020, Journal of the American Geriatrics Society.
[25] Bo Chen,et al. Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial , 2020, medRxiv.
[26] J. Joven,et al. Risk factors associated with mortality in hospitalized patients with SARS-CoV-2 infection. A prospective, longitudinal, unicenter study in Reus, Spain , 2020, bioRxiv.
[27] Q. Ma,et al. Prevalence and clinical features of 2019 novel coronavirus disease (COVID-19) in the Fever Clinic of a teaching hospital in Beijing: a single-center, retrospective study , 2020, medRxiv.
[28] Heng Fan,et al. Diabetes is a risk factor for the progression and prognosis of COVID‐19 , 2020, Diabetes/metabolism research and reviews.
[29] Ting Yu,et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study , 2020, The Lancet Respiratory Medicine.
[30] Xin Zhou,et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China , 2020, The Journal of Emergency Medicine.
[31] Robert G. D. Steel,et al. A multiple comparison rank sum test: Treatments versus control. , 1959 .
[32] Jieyun Zhu,et al. Clinicopathological characteristics of 8697 patients with COVID-19 in China: a meta-analysis , 2020, Family Medicine and Community Health Journal.
[33] Lei Liu,et al. Relationship between the ABO Blood Group and the COVID-19 Susceptibility , 2020, medRxiv.
[34] Kai Liu,et al. Clinical features of COVID-19 in elderly patients: A comparison with young and middle-aged patients , 2020, Journal of Infection.
[35] A. Pan,et al. Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19 , 2020, Journal of Infection.
[36] N. Uriel,et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter , 2020, American Journal of Transplantation.
[37] Jing Shi,et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan , 2020, Journal of Allergy and Clinical Immunology.
[38] Depei Wu,et al. The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China , 2020, Thrombosis Research.
[39] Victor M Corman,et al. Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series , 2020, The Lancet Infectious Diseases.
[40] Chang Hu,et al. Clinical features and short-term outcomes of 221 patients with COVID-19 in Wuhan, China , 2020, Journal of Clinical Virology.
[41] Hangyuan Guo,et al. Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis , 2020, Journal of Infection.
[42] E. Shahverdi,et al. Distribution of blood groups in the Iranian general population , 2016, Immunohematology.
[43] Fang Lei,et al. Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes , 2020, Cell Metabolism.
[44] Heshui Shi,et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet Infectious Diseases.
[45] Kari Stefansson,et al. Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.
[46] Zhanju Liu,et al. Clinical Features of COVID-19-Related Liver Functional Abnormality , 2020, Clinical Gastroenterology and Hepatology.
[47] G. B. Tan,et al. Hematologic parameters in patients with COVID‐19 infection , 2020, American journal of hematology.
[48] Thomas J Oxley,et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young , 2020, The New England journal of medicine.
[49] Yan Zhao,et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19 , 2020, Journal of Infection.
[50] E. Barnes,et al. Determining risk factors for mortality in liver transplant patients with COVID-19 , 2020, The Lancet Gastroenterology & Hepatology.
[51] S. Kim,et al. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients , 2020, Journal of Korean medical science.
[52] R. Alizadeh-Navaei,et al. Evaluation of Hepatic Enzymes Changes and Association with Prognosis in COVID-19 Patients , 2020, Hepatitis Monthly.
[53] I. Youngster,et al. SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults. , 2020, JAMA.
[54] J. Xiang,et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.
[55] Cheng Zheng,et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China , 2020, Infection.
[56] F. Cheng,et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China , 2020, Clinical Microbiology and Infection.
[57] S. Blakemore,et al. Peer Influence in Adolescence: Public-Health Implications for COVID-19 , 2020, Trends in Cognitive Sciences.
[58] W. Liang,et al. Risk Factors of Fatal Outcome in Hospitalized Subjects With Coronavirus Disease 2019 From a Nationwide Analysis in China , 2020, Chest.
[59] Xin Li,et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features , 2020, American journal of respiratory and critical care medicine.
[60] Kun Chen,et al. Characteristics of COVID-19 infection in Beijing , 2020, Journal of Infection.
[61] S. Lei,et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection , 2020, EClinicalMedicine.